References
- Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 1964; 107: 159–71
- Ferriss JB, Beevers DG, Brown JJ, Davies DL, Fraser R, Lever AF. Clinical biochemical and pathological features of low renin (“primary”) hyperaldosteronism. Am Heart J 1978; 95: 375–88
- Brown JJ, Chinn RH, Dusterdieck GO. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty patients. Proc Roy Soc Med 1969; 62: 1259–60
- Laragh JH, Sealey JE, Atlas SA. The renin system for understanding human hypertension :evidence for blood pressure control by bipolar vasoconstriction-volume mechanism. Protein as a determinant of renin secretion. Clin Exp Hypertens 1982; A4: 2303–37
- Kaplan NM. Primary aldosteronism with malignant hypertension. N Engl J Med 1963; 269: 1283–6
- Del Greco F, Dolkart R, Skom J, Method H. Association of accelerated [malignant] hypertension in a patient with primary aldosteronism. J Clin Endocrinol 1966; 26: 808–14
- Aloia JF, Beutow G. Malignant hypertension with aldosterone producing adenoma. Am J Med Sci 1974; 268: 241–5
- Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Figgord RW. The changing clinical spectrum of primary aldosteronism. Am J Med 1983; 74: 641
- Sunman W, Rothwell M, Sever PS. Conn's syndrome can cause malignant hypertension. J Hum Hypertens 1992; 6: 75–6
- Suk-Hee Yu, Whitworth JA, Kincaid-Smith PS. Malignant hypertension: Aetiology and outcome in 83 patients. Clin Exp Theory Prac 1986; A8: 1211–30
- Webster J, Petrie JC, Jeffers TA, Lovel HG. Accelerated hypertension—patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med 1993; 86: 485–93
- Lip GYH, Beevers M, Beevers DG. The failure of malignant hypertension to decline: A survey of 24 years experience. J Hypertens 1994; 12: 1297–305
- Keith NM, Wagener HP, Barker NW. Same different types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336–45
- Vaughan NJA, Slater JDH, Lightman SL. The diagnosis of primary hyperaldosteronism. Lancet 1981; i: 120–5
- Brill GC, Creamer B, Mills IH, Pullan JM. Hyperaldosteronism: report of a case. BMJ 1960; 2: 990–91
- Luetscher JA. Primary hyperaldosteronism: observations in six cases and review of diagnostic procedures. Medicine (Baltimore) 1964; 43: 437–57
- McAllister RG, van Way CW, Dayani K. Malignant hypertension: effect of therapy on renin and aldosterone. Circ Res 1971; 28/29: 177–93